How Massachusetts Biotech Teams Reconcile Clinical-Trial Site Accounts in Salesforce

Why Do Trial-Site Name Variants Matter to Massachusetts Biotech Teams?

In this anonymized composite scenario, a Massachusetts biotech sponsor imports clinical-trial facility records from a registry and two CRO feeds into Salesforce. Variant names create duplicate Site Accounts, while a broad name match risks collapsing separate campuses. An illustrative 15,000-row review shows how the team can verify each physical facility, preserve separate study-site relationships, preview approved ZaapIT corrections, and retain backup, bulk undo, and restore for supported updates. This is not a named customer result.

Presenter beside an illustrative clinical-trial facility and study relationship diagram
Illustrative visual: one verified physical facility can participate in several distinct studies.

Read More